* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Table 13. Drug Metabolism Basics Bioavailability and Half
Survey
Document related concepts
Orphan drug wikipedia , lookup
Compounding wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Psychopharmacology wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacognosy wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Drug discovery wikipedia , lookup
Prescription costs wikipedia , lookup
Neuropharmacology wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Drug design wikipedia , lookup
Plateau principle wikipedia , lookup
Transcript
Table 13. Drug Metabolism Basics Bioavailability and Half-Life: Cannot predict bioavailability and half-life on just one pharmacokinetic parameter Absorption: What proportion (percent) of an oral drug gets from the GI tract into the blood? Distribution: Where does the drug go? • Lipophilic = distributes through membranes with preference for adipose tissue and muscle (greater volume of distribution) • Hydrophilic = remains mostly in blood compartment until the drug is eliminated • An increase in the volume of distribution of a drug will generally increase its elimination half-life • A decrease in volume of distribution with an increase in elimination clearance will generally decrease elimination half-life Metabolism: How is the drug changed so it can be excreted? • The quicker the metabolism, the shorter the half-life • The liver is the major site for drug metabolism, but biotransformation can also occur by the kidney and intestine • Conversion of lipophilic drugs to more polar metabolites by the liver may increase excretion in the bile and kidney, and thus may decrease half-life Excretion: How does the drug leave the blood (e.g. urine)? • The quicker the excretion, the shorter the half-life • Polar, hydrophilic drugs may have increased excretion in the urine Lipophilic drugs More likely to be metabolized, creating metabolites that are likely more polar, and then more easily excreted. • Phase 1 = Convert lipophilic molecules into more polar molecules (hydrolysis, oxidation, reduction) • Phase 2 = Further convert lipophilic molecules into more polar molecules through conjugation with glucuronic acid, sulfuric acid, acetic acid, or amino acid. If reabsorbed and recirculated, then this may increase half-life • Increased tubular reabsorption • Enterohepatic recirculation Hydrophilic drugs More likely to be excreted unchanged by the kidney. Kidney: • Decrease half-life = Increased glomerular filtration and/or tubular secretion • Increase half-life = Increased protein binding may reduce glomerular filtration of drug